Skip to main content

The influence of intravenous amifostine on xerostomia and survival during radiotherapy for head and neck cancer: Two year follow-up of a prospective randomized trial.

Publication ,  Conference
Brizel, DM; Wasserman, T
Published in: JOURNAL OF CLINICAL ONCOLOGY
July 15, 2004

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

497S / 497S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brizel, D. M., & Wasserman, T. (2004). The influence of intravenous amifostine on xerostomia and survival during radiotherapy for head and neck cancer: Two year follow-up of a prospective randomized trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 497S-497S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY.
Brizel, D. M., and T. Wasserman. “The influence of intravenous amifostine on xerostomia and survival during radiotherapy for head and neck cancer: Two year follow-up of a prospective randomized trial.” In JOURNAL OF CLINICAL ONCOLOGY, 22:497S-497S. AMER SOC CLINICAL ONCOLOGY, 2004.
Brizel, D. M., and T. Wasserman. “The influence of intravenous amifostine on xerostomia and survival during radiotherapy for head and neck cancer: Two year follow-up of a prospective randomized trial.JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, AMER SOC CLINICAL ONCOLOGY, 2004, pp. 497S-497S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

497S / 497S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences